These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34476527)

  • 21. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
    Zhou X; Wu C; Cheng Q
    Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
    Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Seitz C; Sun M; Karakiewicz PI; Schramek P; Herman MP; Becker A; Hansen J; Ehdaie B; Loidl W; Pummer K; Lee RK; Lotan Y; Scherr DS; Seiler D; Ahyai SA; Chun FK; Graefen M; Tewari A; Nonis A; Bachmann A; Montorsi F; Gönen M; Briganti A; Shariat SF
    Br J Cancer; 2014 Jul; 111(2):213-9. PubMed ID: 25003663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
    Goldsmith B; Baumann BC; He J; Tucker K; Bekelman J; Deville C; Vapiwala N; Vaughn D; Keefe SM; Guzzo T; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):603-10. PubMed ID: 24411628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy.
    Taylor MA; Alemozaffar M; Master VA; Sanda MG; Filson CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e494-e504. PubMed ID: 30819637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone.
    Seyedin SN; Mitchell DL; Mott SL; Russo JK; Tracy CR; Snow AN; Parkhurst JR; Smith MC; Buatti JM; Watkins JM
    Pathol Oncol Res; 2019 Jan; 25(1):209-215. PubMed ID: 29079967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
    [No Abstract]   [Full Text] [Related]  

  • 30. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer.
    Ginsburg KB; Pressprich MF; Wurst HA; Cher ML
    Curr Probl Cancer; 2021 Dec; 45(6):100740. PubMed ID: 33931243
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Ferraro DA; Muehlematter UJ; Garcia Schüler HI; Rupp NJ; Huellner M; Messerli M; Rüschoff JH; Ter Voert EEGW; Hermanns T; Burger IA
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):147-159. PubMed ID: 31522272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with
    Yaxley JW; Raveenthiran S; Nouhaud FX; Samartunga H; Yaxley AJ; Coughlin G; Delahunt B; Egevad L; McEwan L; Wong D
    J Urol; 2019 Apr; 201(4):815-820. PubMed ID: 30672842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
    Wagner M; Sokoloff M; Daneshmand S
    J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
    Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications for pelvic lymphadenectomy in prostate cancer.
    Link RE; Morton RA
    Urol Clin North Am; 2001 Aug; 28(3):491-8. PubMed ID: 11590808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy.
    Ramírez-Backhaus M; Mira Moreno A; Gómez Ferrer A; Calatrava Fons A; Casanova J; Solsona Narbón E; Ortiz Rodríguez IM; Rubio Briones J
    J Urol; 2016 Nov; 196(5):1429-1435. PubMed ID: 27235788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
    Tilki D; Reich O; Graser A; Hacker M; Silchinger J; Becker AJ; Khoder W; Bartenstein P; Stief CG; Loidl W; Seitz M
    Eur Urol; 2013 May; 63(5):792-6. PubMed ID: 22902037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.